Resilience to bacterial infection: difference between species could be due to proteins in serum.

Vertebrates vary in resistance and resilience to infectious diseases, and the mechanisms that regulate the trade-off between these often opposing protective processes are not well understood. Variability in the sensitivity of species to the induction of damaging inflammation in response to equivalent pathogen loads (resilience) complicates the use of animal models that reflect human disease. We found that induction of proinflammatory cytokines from macrophages in response to inflammatory stimuli in vitro is regulated by proteins in the sera of species in inverse proportion to their in vivo resilience to lethal doses of bacterial lipopolysaccharide over a range of 10,000-fold. This finding suggests that proteins in serum rather than intrinsic cellular differences may play a role in regulating variations in resilience to microbe-associated molecular patterns between species. The involvement of circulating proteins as key molecules raises hope that the process might be manipulated to create better animal models and potentially new drug targets.

[1]  David S Schneider,et al.  Two ways to survive infection: what resistance and tolerance can teach us about treating infectious diseases , 2008, Nature Reviews Immunology.

[2]  D. Sim,et al.  Disentangling Genetic Variation for Resistance and Tolerance to Infectious Diseases in Animals , 2007, Science.

[3]  Hae-Sook Shin,et al.  MyD88-Dependent and MyD88-Independent Pathways in Synergy, Priming, and Tolerance between TLR Agonists1 , 2007, The Journal of Immunology.

[4]  M. Adib-Conquy,et al.  Bench-to-bedside review: Endotoxin tolerance as a model of leukocyte reprogramming in sepsis , 2006, Critical care.

[5]  S. Akira,et al.  Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response , 2006, Nature Immunology.

[6]  Rudi Beyaert,et al.  Up-regulation of MyD88s and SIGIRR, molecules inhibiting Toll-like receptor signaling, in monocytes from septic patients* , 2006, Critical care medicine.

[7]  D. Morel,et al.  Evaluation of unfractionated heparin and recombinant hirudin on survival in a sustained ovine endotoxin shock model , 2002, Critical care medicine.

[8]  J. Peters,et al.  Pretreatment with troglitazone decreases lethality during endotoxemia in mice , 2002, Journal of endotoxin research.

[9]  Jesse D. Roberts,et al.  Bacterial Peptidoglycan-associated Lipoprotein Is Released into the Bloodstream in Gram-negative Sepsis and Causes Inflammation and Death in Mice* , 2002, The Journal of Biological Chemistry.

[10]  T. Yoshino,et al.  Inhibitory effect on LPS-induced tumor necrosis factor in calves treated with chlorpromazine or pentoxifylline. , 1997, The Journal of veterinary medical science.

[11]  J. Cavaillon,et al.  IL-10 and IL-4 synergize with TNF-α to induce IL-1ra production by human neutrophils , 1996 .

[12]  S. Lowry,et al.  Biological Responses to Endotoxin in Humans1 , 1995 .

[13]  C. Natanson,et al.  Differential hemodynamic effects of L-NMMA in endotoxemic and normal dogs. , 1995, The American journal of physiology.

[14]  W. Baze,et al.  Increased susceptibility to staphylococcal enterotoxin B intoxication in mice primed with actinomycin D , 1994, Infection and immunity.

[15]  R. Danner,et al.  Brief report: shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin. , 1993, The New England journal of medicine.

[16]  J. Cavaillon,et al.  Assessment of ability of murine and human anti-lipid A monoclonal antibodies to bind and neutralize lipopolysaccharide , 1993, The Journal of experimental medicine.

[17]  A. Severn,et al.  A convenient human whole blood culture system for studying the regulation of tumour necrosis factor release by bacterial lipopolysaccharide. , 1991, Journal of immunological methods.

[18]  M. Hansen,et al.  Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. , 1989, Journal of immunological methods.

[19]  R. Ulevitch,et al.  Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. , 1988, The Journal of clinical investigation.

[20]  Kevin J. Tracey,et al.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia , 1987, Nature.

[21]  D. Golenbock,et al.  Lipid X ameliorates pulmonary hypertension and protects sheep from death due to endotoxin , 1987, Infection and immunity.

[22]  C. Galanos,et al.  Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin , 1986, Infection and immunity.

[23]  B. Beutler,et al.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. , 1985, Science.

[24]  R. McCuskey,et al.  Species differences in Kupffer cells and endotoxin sensitivity , 1984, Infection and immunity.

[25]  R. Goldfarb,et al.  Canine left ventricular performance during LD50 endotoxemia. , 1983, The American journal of physiology.

[26]  C. Wolfensberger,et al.  INTERFERON IN HUMAN SERUM AFTER INJECTION OF ENDOTOXIN , 1980, The Lancet.

[27]  C. T. Liu,et al.  Modification of lethality induced by staphylococcal enterotoxin B in Dutch rabbits. , 1980, American journal of veterinary research.

[28]  R. Macdermott,et al.  Genetic control of susceptibility to Salmonella typhimurium in mice: role of the LPS gene. , 1980, Journal of immunology.

[29]  D. Rosenstreich,et al.  Significant contribution of spleen cells in mediating the lethal effects of endotoxin in vivo , 1976, Infection and immunity.

[30]  J. Sheagren,et al.  Febrile and hematologic responses of rhesus monkeys to bacterial endotoxin. , 1967, The American journal of physiology.

[31]  I. Berczi,et al.  Comparative studies on the toxicity of Escherichia coli lipopolysaccharide endotoxin in various animal species. , 1966, Canadian journal of microbiology.

[32]  R. Dubos,et al.  THE SUSCEPTIBILITY OF MICE TO BACTERIAL ENDOTOXINS , 1961, The Journal of experimental medicine.

[33]  R. Munford.  Detoxifying endotoxin: time, place and person. , 2005, Journal of endotoxin research.

[34]  J. Cavaillon,et al.  IL-10 and IL-4 synergize with TNF-alpha to induce IL-1ra production by human neutrophils. , 1996, Cytokine.

[35]  J. Tellado,et al.  Modulation of the inflammatory response in severe sepsis , 1995 .

[36]  I. Clark.  Correlation between susceptibility to malaria and babesia parasites and to endotoxicity. , 1982, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[37]  J. Mcghee,et al.  The primary role of lymphoreticular cells in the mediation of host responses to bacterial endotoxim. , 1980, The Journal of infectious diseases.

[38]  H. Adler,et al.  Toxicity of endotoxin to chicks. , 1979, Avian diseases.